Help For African Americans With High Cholesterol

Monday, March 1, 2004

New Help For African Americans With High Cholesterol (NAPSA)—While statin medications have helped millions of patients lower their cholesterol levels, until now, little has been known about how African Americans respond to statin therapy. This is because African Americans are typically underrepresented in clinical trials. One study, called ARIES (Afriean American Rosuvastatin Investigation of Efficacy and Safety), presented at the American Heart Association’s Scientific Sessions, is the first-ever largescale, prospective trial exclusively designed to compare the effects of statins in African-American patients. ARIES evaluated the efficacy of AstraZeneca’s cholesterol lowering statin Crestor (rosuvastatin calcium) and atorvastatin in African Americans with elevated cholesterol and found that Crestor at 10 and 20mg reduced LDL-C or “bad” cholesterol by 37 and 46 percent, compared to 32 and 39 percent at similar doses with atorvastatin in AfricanAmerican patients (p

--- PHOTOS ---

File: 20190731-154621-20190731-154618-62911.pdf.jpg

--- FILES ---

File: 20190731-154618-62911.pdf